A genetic roadmap of pancreatic cancer: still evolving.

Main|Search|PHGKB




Last Posted: Nov 04, 2017

---

• A genetic roadmap of pancreatic cancer: still evolving.  
  Notta Faiyaz et al. Gut 2017 Oct
• Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma  
  ZR Qiang et al, JAMA Oncology, Nov 3, 2017
• Circulating microRNAs Expressions as Genetic Biomarkers in Pancreatic Cancer Patients Continuous Non-Invasive Monitoring.  
  Sandesc Mihai et al. Clinical laboratory 2017 Oct (10) 1561-1566
• 5 Things to Know about BRCA Mutations and Pancreatic Cancer  
  Pancreatic Cancer Action Network, October 12, 2017
• Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.  
  Yang Sujuan et al. Cancer biology & therapy 2017 Mar 18(3) 158-165
• MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer - A systematic review and meta-analysis.  
  Negoi Ionut et al. American journal of surgery 2017 Sep 214(3) 515-524
• Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.  
  Lowery Maeve A et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jul
• Pancreatic Cancer Screening.  
  Das Koushik K et al. Current treatment options in gastroenterology 2017 Sep
• Familial pancreatic cancer: Concept, management and issues.  
  Matsubayashi Hiroyuki et al. World journal of gastroenterology 2017 Feb 23(6) 935-948
• DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development.  
  Golan Talia et al. Journal of the National Comprehensive Cancer Network : JNCCN 2017 Aug 15(8) 1063-1069
• Dual-Biomarker Blood Test Shows Promise for Pancreatic Cancer Early Detection  
  NCI News, August 9, 2017
• Genomics in Primary and Secondary Prevention of Pancreatic Cancer.  
  Malats Núria et al. Public health genomics 2017 Jul
• Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.  
  Oba Atsushi et al. Journal of hepato-biliary-pancreatic sciences 2016 Aug 23(8) 480-8
• Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.  
  Chaffee Kari G et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Jul
• Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history  
  KG Chaffee et al, Genetics in Medicine, July 20, 2017
• Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.  
  McAllister Florencia et al. Gastroenterology & hepatology 2017 May 13(5) 268-275

more